Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 USD | -2.17% | -11.25% | -73.48% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 5.26M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -14M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.48
x | P/E ratio 2025 * |
-0.47
x | Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.74% |
Latest transcript on Processa Pharmaceuticals, Inc.
1 day | -2.17% | ||
1 week | -11.25% | ||
Current month | -18.58% | ||
1 month | +10.94% | ||
3 months | -19.32% | ||
6 months | -81.12% | ||
Current year | -73.48% |
Managers | Title | Age | Since |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 11-03-28 |
Sian Bigora
FOU | Founder | 63 | 11-03-28 |
David Young
FOU | Founder | 71 | 11-03-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 23-08-07 |
James Neal
BRD | Director/Board Member | 68 | 22-07-15 |
Justin Yorke
CHM | Chairman | 58 | 17-10-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 1.775 | -3.53% | 24 472 |
24-05-22 | 1.84 | -3.16% | 28,234 |
24-05-21 | 1.9 | -2.06% | 45,113 |
24-05-20 | 1.94 | -1.02% | 30,413 |
24-05-17 | 1.96 | -2.00% | 36,919 |
Delayed Quote Nasdaq, May 23, 2024 at 02:22 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-73.48% | 5.26M | |
+38.08% | 723B | |
+34.28% | 595B | |
-4.48% | 369B | |
+20.11% | 332B | |
+2.73% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.03% | 168B |
- Stock Market
- Equities
- PCSA Stock